Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ACAD |
---|---|---|
09:32 ET | 7900 | 15.07 |
09:34 ET | 200 | 15.05 |
09:36 ET | 3333 | 15.12 |
09:38 ET | 1567 | 15.1485 |
09:39 ET | 31055 | 15.15 |
09:41 ET | 6500 | 15.17 |
09:43 ET | 6833 | 15.19 |
09:45 ET | 1300 | 15.165 |
09:48 ET | 7815 | 15.08 |
09:50 ET | 7057 | 15.125 |
09:52 ET | 6683 | 15.17 |
09:54 ET | 13416 | 15.115 |
09:56 ET | 1550 | 15.11 |
09:57 ET | 1155 | 15.1 |
09:59 ET | 1200 | 15.1 |
10:01 ET | 2400 | 15.09 |
10:03 ET | 600 | 15.08 |
10:06 ET | 2799 | 15.11 |
10:08 ET | 1223 | 15.1 |
10:10 ET | 800 | 15.1 |
10:12 ET | 5158 | 15.1299 |
10:14 ET | 2012 | 15.14 |
10:15 ET | 400 | 15.13 |
10:17 ET | 586 | 15.15 |
10:19 ET | 2621 | 15.1687 |
10:21 ET | 1600 | 15.17 |
10:24 ET | 2167 | 15.19 |
10:26 ET | 2753 | 15.14 |
10:28 ET | 550 | 15.14 |
10:30 ET | 2100 | 15.14 |
10:32 ET | 2064 | 15.15 |
10:33 ET | 1804 | 15.18 |
10:35 ET | 1800 | 15.14 |
10:37 ET | 3451 | 15.14 |
10:39 ET | 1740 | 15.15 |
10:42 ET | 1772 | 15.16 |
10:44 ET | 910 | 15.15 |
10:46 ET | 400 | 15.135 |
10:48 ET | 800 | 15.125 |
10:50 ET | 1004 | 15.12 |
10:51 ET | 500 | 15.12 |
10:53 ET | 200 | 15.13 |
10:55 ET | 3266 | 15.1 |
10:57 ET | 4002 | 15.07 |
11:00 ET | 700 | 15.08 |
11:02 ET | 1557 | 15.07 |
11:04 ET | 884 | 15.04 |
11:06 ET | 1081 | 15.045 |
11:08 ET | 8545 | 15.055 |
11:09 ET | 1937 | 15.1 |
11:11 ET | 1100 | 15.115 |
11:13 ET | 630 | 15.115 |
11:15 ET | 1100 | 15.11 |
11:18 ET | 953 | 15.105 |
11:20 ET | 2215 | 15.1 |
11:22 ET | 1200 | 15.1 |
11:24 ET | 1434 | 15.09 |
11:26 ET | 592 | 15.09 |
11:27 ET | 800 | 15.11 |
11:29 ET | 1000 | 15.11 |
11:31 ET | 2400 | 15.13 |
11:33 ET | 1817 | 15.11 |
11:36 ET | 700 | 15.099 |
11:38 ET | 950 | 15.09 |
11:40 ET | 893 | 15.09 |
11:42 ET | 700 | 15.1 |
11:44 ET | 1100 | 15.1 |
11:45 ET | 1431 | 15.1 |
11:47 ET | 2148 | 15.125 |
11:49 ET | 100 | 15.13 |
11:51 ET | 800 | 15.11 |
11:54 ET | 1764 | 15.13 |
11:56 ET | 1200 | 15.12 |
11:58 ET | 600 | 15.12 |
12:00 ET | 635 | 15.12 |
12:02 ET | 1000 | 15.11 |
12:03 ET | 1634 | 15.11 |
12:05 ET | 200 | 15.12 |
12:07 ET | 342 | 15.12 |
12:09 ET | 900 | 15.125 |
12:12 ET | 2171 | 15.112 |
12:14 ET | 1144 | 15.1 |
12:16 ET | 200 | 15.1025 |
12:18 ET | 1641 | 15.125 |
12:20 ET | 2203 | 15.13 |
12:21 ET | 2289 | 15.13 |
12:23 ET | 898 | 15.14 |
12:25 ET | 1350 | 15.14 |
12:27 ET | 3086 | 15.135 |
12:30 ET | 1726 | 15.145 |
12:32 ET | 843 | 15.145 |
12:34 ET | 575 | 15.15 |
12:36 ET | 4335 | 15.11 |
12:38 ET | 507 | 15.11 |
12:39 ET | 2554 | 15.11 |
12:41 ET | 900 | 15.11 |
12:43 ET | 740 | 15.105 |
12:45 ET | 1027 | 15.095 |
12:48 ET | 1300 | 15.105 |
12:50 ET | 900 | 15.11 |
12:52 ET | 5279 | 15.1 |
12:54 ET | 1200 | 15.11 |
12:56 ET | 700 | 15.105 |
12:57 ET | 200 | 15.11 |
12:59 ET | 812 | 15.11 |
01:01 ET | 300 | 15.11 |
01:03 ET | 1400 | 15.11 |
01:06 ET | 12937 | 15.1 |
01:12 ET | 2661 | 15.1 |
01:14 ET | 600 | 15.12 |
01:15 ET | 1810 | 15.13 |
01:17 ET | 2315 | 15.11 |
01:19 ET | 900 | 15.09 |
01:21 ET | 600 | 15.09 |
01:24 ET | 2036 | 15.09 |
01:26 ET | 629 | 15.08 |
01:28 ET | 3750 | 15.09 |
01:30 ET | 700 | 15.095 |
01:32 ET | 500 | 15.1 |
01:33 ET | 727 | 15.09 |
01:35 ET | 2605 | 15.07 |
01:37 ET | 850 | 15.075 |
01:39 ET | 1916 | 15.07 |
01:42 ET | 1100 | 15.06 |
01:44 ET | 2100 | 15.075 |
01:46 ET | 1315 | 15.1 |
01:48 ET | 2200 | 15.09 |
01:50 ET | 100 | 15.08 |
01:51 ET | 811 | 15.09 |
01:53 ET | 2206 | 15.0985 |
01:55 ET | 2884 | 15.09 |
01:57 ET | 939 | 15.1 |
02:00 ET | 1100 | 15.09 |
02:02 ET | 900 | 15.09 |
02:04 ET | 400 | 15.1 |
02:06 ET | 900 | 15.09 |
02:08 ET | 502 | 15.095 |
02:09 ET | 2768 | 15.1 |
02:11 ET | 1800 | 15.1 |
02:13 ET | 800 | 15.12 |
02:15 ET | 2736 | 15.1 |
02:18 ET | 2069 | 15.1 |
02:20 ET | 4043 | 15.1 |
02:22 ET | 1194 | 15.1 |
02:24 ET | 1186 | 15.105 |
02:26 ET | 1540 | 15.09 |
02:27 ET | 1198 | 15.085 |
02:29 ET | 1049 | 15.09 |
02:31 ET | 18560 | 15.05 |
02:33 ET | 6519 | 15.035 |
02:36 ET | 6853 | 15.02 |
02:38 ET | 1100 | 15.025 |
02:40 ET | 19258 | 15.005 |
02:42 ET | 4318 | 15 |
02:44 ET | 26217 | 15.05 |
02:45 ET | 11442 | 15.04 |
02:47 ET | 12979 | 15.03 |
02:49 ET | 2176 | 15.04 |
02:51 ET | 20869 | 15.08 |
02:54 ET | 400 | 15.07 |
02:56 ET | 1991 | 15.075 |
02:58 ET | 700 | 15.08 |
03:00 ET | 1211 | 15.09 |
03:02 ET | 4012 | 15.09 |
03:03 ET | 6508 | 15.04 |
03:05 ET | 4705 | 15.085 |
03:07 ET | 11168 | 15.09 |
03:09 ET | 2928 | 15.09 |
03:12 ET | 450 | 15.095 |
03:14 ET | 4445 | 15.1 |
03:16 ET | 1243 | 15.08 |
03:18 ET | 1339 | 15.08 |
03:20 ET | 1366 | 15.07 |
03:21 ET | 1529 | 15.07 |
03:23 ET | 603 | 15.075 |
03:25 ET | 2644 | 15.08 |
03:27 ET | 1488 | 15.08 |
03:30 ET | 1656 | 15.08 |
03:32 ET | 1720 | 15.1 |
03:34 ET | 1447 | 15.09 |
03:36 ET | 1176 | 15.09 |
03:38 ET | 3325 | 15.0801 |
03:39 ET | 8004 | 15.095 |
03:41 ET | 3740 | 15.1 |
03:43 ET | 1665 | 15.105 |
03:45 ET | 11070 | 15.114 |
03:48 ET | 2543 | 15.12 |
03:50 ET | 14615 | 15.11 |
03:52 ET | 48366 | 15.09 |
03:54 ET | 11059 | 15.095 |
03:56 ET | 18004 | 15.095 |
03:57 ET | 21527 | 15.09 |
03:59 ET | 34190 | 15.1 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
ACADIA Pharmaceuticals Inc | 2.5B | -1,173.3x | --- |
Azenta Inc | 2.7B | -18.4x | --- |
PTC Therapeutics Inc | 2.8B | -4.7x | --- |
Guardant Health Inc | 3.3B | -6.9x | --- |
Novavax Inc | 2.1B | -4.7x | --- |
Amicus Therapeutics Inc | 2.9B | -19.9x | --- |
Acadia Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has a portfolio of commercial stage products, in-development product opportunities, and research programs that are designed to address unmet needs in CNS disorders and rare diseases. Its pipeline includes NUPLAZID (pimavanserin), DAYBUE (trofinetide), ACP-101, ACP-204, and Antisense Oligonucleotide (ASO) Programs. NUPLAZID is a selective serotonin inverse agonist/antagonist preferentially targeting the 5-HT2A receptor. NUPLAZID is developed for the treatment for Parkinson's Disease Psychosis. Trofinetide is a novel synthetic analog of the amino-terminal tripeptide of insulin-like growth factor 1 (IGF-1) designed to treat the core symptoms of Rett syndrome by reducing neuroinflammation and supporting synaptic function.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.5B |
---|---|
Revenue (TTM) | $813.8M |
Shares Outstanding | 165.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.40 |
EPS | $-0.01 |
Book Value | $2.62 |
P/E Ratio | -1,173.3x |
Price/Sales (TTM) | 3.1 |
Price/Cash Flow (TTM) | 278.9x |
Operating Margin | -0.56% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.